Research ArticleOncology
18F-Fluoromisonidazole Kinetic Modeling for Characterization of Tumor Perfusion and Hypoxia in Response to Antiangiogenic Therapy
Milan Grkovski, Sally-Ann Emmas and Sean D. Carlin
Journal of Nuclear Medicine October 2017, 58 (10) 1567-1573; DOI: https://doi.org/10.2967/jnumed.117.190892
Milan Grkovski
1Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
Sally-Ann Emmas
2Imaging Team, Personalised Healthcare and Biomarkers, AstraZeneca, Macclesfield, United Kingdom; and
Sean D. Carlin
3Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 58, Issue 10
October 1, 2017
18F-Fluoromisonidazole Kinetic Modeling for Characterization of Tumor Perfusion and Hypoxia in Response to Antiangiogenic Therapy
Milan Grkovski, Sally-Ann Emmas, Sean D. Carlin
Journal of Nuclear Medicine Oct 2017, 58 (10) 1567-1573; DOI: 10.2967/jnumed.117.190892